Symbol="KRON"
AssetType="Common Stock"
Name="Kronos BioÂ Inc"
Description="Kronos Bio, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of new cancer therapies. The company is headquartered in San Mateo, California."
CIK="1741830"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1300 S. EL CAMINO REAL, SUITE 300, SAN MATEO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="125634000"
EBITDA="-126965000"
PERatio="None"
PEGRatio="None"
BookValue="3.934"
DividendPerShare="0"
DividendYield="0"
EPS="-2.29"
RevenuePerShareTTM="0.022"
ProfitMargin="0"
OperatingMarginTTM="-105.85"
ReturnOnAssetsTTM="-0.247"
ReturnOnEquityTTM="-0.454"
RevenueTTM="1221000"
GrossProfitTTM="0"
DilutedEPSTTM="-2.29"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="10.2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.419"
EVToRevenue="-"
EVToEBITDA="0.701"
Beta="1.451"
num_52WeekHigh="5.74"
num_52WeekLow="1.2"
num_50DayMovingAverage="1.786"
num_200DayMovingAverage="1.939"
SharesOutstanding="57630000"
DividendDate="None"
ExDividendDate="None"
symbol="KRON"
open="2.18"
high="2.22"
low="1.93"
price="1.96"
volume="190374.00"
latest_trading_day="2023-07-24"
previous_close="2.18"
change="-0.22"
change_percent="-10.0917%"
aroon_positive_momentum_days="60"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="60"
Volume_recent_avg="356961"
Change_recent_avg="0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.37"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_45"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="60"
Aroon_momentum_negative="40"
image_negative_thumbnail_id_1="515"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_negative_thumbnail_id_2="1116"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0149.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="974"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0136.jpeg"
image_positive_thumbnail_id_2="964"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
